Enro 10% Liquid Solution

For use in the treatment of diseases of the respiratory and alimentary tracts of bacterial or mycoplasmal origin (e g pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Enrofloxacin: 100g/L

The product is administered via the drinking water. Medicated water should be made up immediately prior to provision. Medication of the water supply should be continuous during the treatment period and no other source of water should be available. The product should be given over a minimum period of 6 hours per day to allow all birds to drink.

Poultry and Turkeys : The dose rate is 10 mg/kg bodyweight daily for 3 to 10 days.

Each ml contains 100 mg enrofloxacin. Calculate the daily quantity (ml) of product required for treatment period as follows :

Total number of birds x Average body weight in kg x 0.1 = Total volume (ml) per day

The product may be put directly into the header tank or introduced via a water proportioner pump. For the treatment of salmonellosis or pasteurellosis a treatment period of 5 to 10 days must be used. For other conditions the duration of treatment may be 3 to 5 days.

For slaughter withdrawal, 28 days. Eggs: Contraindicated (not for use in birds producing eggs for human consumption)

Store in a cool dry place (≤ 25°C). Strictly avoid light & heat exposure

SHELF LIFE : 36 months

SHELF LIFE after first opening: Keep tightly after open. Use within 3 months

SHELF LIFE after dilution: Finish treatment within 12 hours after dilution

Use under Veterinarian recommendation. Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Whenever possible, fluoroquinolones should only be used based on susceptibility testing. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross resistance. Keep out of reach of children

Any unused veterinary product or waste materials derived from such veterinary medicinal products should be disposed of an accordance with local requirements